Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease
Harvijay Singh, Rajat Mudgal, M. Narwal, et al.
Biochimie (2018) Vol. 149, pp. 51-61
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
Shweta Choudhary, Yashpal Singh Malik, Shailly Tomar
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 197
Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, et al.
Journal of Molecular Liquids (2020) Vol. 320, pp. 114493-114493
Open Access | Times Cited: 96
Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Supreeti Mahajan, Shweta Choudhary, Pravindra Kumar, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116356-116356
Open Access | Times Cited: 83
Antivirals against the Chikungunya Virus
Verena Battisti, Ernst Urban, Thierry Langer
Viruses (2021) Vol. 13, Iss. 7, pp. 1307-1307
Open Access | Times Cited: 59
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2
Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, et al.
Biochemistry (2025)
Closed Access | Times Cited: 1
Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site
M. Narwal, Harvijay Singh, Shivendra Pratap, et al.
International Journal of Biological Macromolecules (2018) Vol. 116, pp. 451-462
Closed Access | Times Cited: 61
Inhibition of Chikungunya virus by an adenosine analog targeting the SAM‐dependent nsP1 methyltransferase
Rajat Mudgal, Supreeti Mahajan, Shailly Tomar
FEBS Letters (2019) Vol. 594, Iss. 4, pp. 678-694
Open Access | Times Cited: 59
Green synthesis of nanometal impregnated biomass – antiviral potential
Shweta Choudhary, Ravi Kumar, Utsav Dalal, et al.
Materials Science and Engineering C (2020) Vol. 112, pp. 110934-110934
Closed Access | Times Cited: 57
Crystal Structure of African Swine Fever Virus pS273R Protease and Implications for Inhibitor Design
Guobang Li, Xiaoxia Liu, Mengyuan Yang, et al.
Journal of Virology (2020) Vol. 94, Iss. 10
Open Access | Times Cited: 42
Alphavirus RNA replication in vertebrate cells
Tero Ahola, Gerald M. McInerney, Andres Merits
Advances in virus research (2021), pp. 111-156
Closed Access | Times Cited: 40
Overview on Chikungunya Virus Infection: From Epidemiology to State-of-the-Art Experimental Models
Larissa E. C. Constant, Bia F. Rajsfus, Pedro Henrique Carneiro, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 34
Glycan-dependent chikungunya viral infection divulged by antiviral activity of NAG specific chi-like lectin
Ramanjit Kaur, N.A. Neetu, Rajat Mudgal, et al.
Virology (2018) Vol. 526, pp. 91-98
Open Access | Times Cited: 39
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection
Benazir Fatma, Ravi Kumar, Vedita Anand Singh, et al.
Antiviral Research (2020) Vol. 179, pp. 104808-104808
Closed Access | Times Cited: 39
Structural insights into Entamoeba histolytica arginase and structure‐based identification of novel non‐amino acid based inhibitors as potential antiamoebic molecules
Anjali Malik, Vikram Dalal, Serge Ankri, et al.
FEBS Journal (2019) Vol. 286, Iss. 20, pp. 4135-4155
Open Access | Times Cited: 39
Evaluation of novobiocin and telmisartan for anti-CHIKV activity
Praveen Tripathi, Anjali Soni, Shiv Pratap Singh Yadav, et al.
Virology (2020) Vol. 548, pp. 250-260
Open Access | Times Cited: 33
A robust fluorogenic substrate for chikungunya virus protease (nsP2) activity
Sparsh Makhaik, Wioletta Rut, Shruti Choudhary, et al.
Protein Science (2025) Vol. 34, Iss. 3
Open Access
Novel peptide inhibitor for the Chikungunya virus nsP2 protease: Identification and Characterization.
Mohammadamin Mastalipour, Ian Gering, Mônika A. Coronado, et al.
Current Research in Microbial Sciences (2025) Vol. 8, pp. 100376-100376
Open Access
Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti‐Alphavirus Therapies
Sainan Wang, Suresh Mahalingam, Andres Merits
Reviews in Medical Virology (2025) Vol. 35, Iss. 2
Open Access
Evaluation of the Antiviral Potential of Halogenated Dihydrorugosaflavonoids and Molecular Modeling with nsP3 Protein of Chikungunya Virus (CHIKV)
Ninad V. Puranik, Ruchi Rani, Vedita Anand Singh, et al.
ACS Omega (2019) Vol. 4, Iss. 23, pp. 20335-20345
Open Access | Times Cited: 34
Computer-Aided Design, Synthesis, and Antiviral Evaluation of Novel Acrylamides as Potential Inhibitors of E3-E2-E1 Glycoproteins Complex from Chikungunya Virus
Gabriel Felipe Silva Passos, Matheus Gabriel Moura Gomes, Thiago Mendonça de Aquino, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 141-141
Open Access | Times Cited: 28
In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases
Raphael J. Eberle, Danilo S. Olivier, Carolina Colombelli Pacca, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0246319-e0246319
Open Access | Times Cited: 26
Selective Estrogen Receptor Modulators Limit Alphavirus Infection by Targeting the Viral Capping Enzyme nsP1
Rajat Mudgal, Chandrima Bharadwaj, Aakriti Dubey, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 17
Viral methyltransferase inhibitors: berbamine, venetoclax, and ponatinib as efficacious antivirals against chikungunya virus
Mandar Bhutkar, Ankita Saha, Shailly Tomar
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110111-110111
Open Access | Times Cited: 3
Repurposing Efavirenz, the HIV Antiretroviral Drug for Chikungunya Virus Infection
Sanketkumar Nehul, Ruchi Rani, Priyanshu Walia, et al.
ACS Infectious Diseases (2025)
Closed Access
Page 1 - Next Page

Scroll to top